Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 1246-1250

  Mizutani, Yoichi ^a   Katsuoka, Yoji ^a   Bonavida, Benjamin ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bladder cancer; Prognosis; Smac DIABLO

Indexed keywords

SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; DISEASE-FREE SURVIVAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84858654896     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1324     Document Type: Article

References (20)

1. Grossman HB, Soloway M and Messing E: Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA 295: 299-305, 2007. (Pubitemid 43112958)
2. Bajorin DF, Dodd PM and Mazumdar M: Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 17: 3173-3181, 1999. (Pubitemid 29470648)
3. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z and Alnemri ES: Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 275: 36152-36157, 2000.
4. Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
5. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53, 2000.
6. Fulda S, Wick W, Weller M and Debatin KM: Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8: 808-815, 2002.
7. Ng CP and Bonavida B: X-linked inhibitor of apoptosis (XIAP) blocks Apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: Sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO). Mol Cancer Ther 1: 1051-1058, 2002.
8. Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B and Miki T: Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol 23: 448-454, 2005. (Pubitemid 46224220)
9. Mizutani Y, Katsuoka Y and Bonavida B: Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy. Int J Oncol 37: 503-508, 2010.
10. Kempkensteffen C, Hinz S, Christoph F, Krause H, Magheli A, Schrader M, Schostak M, Miller K and Wreikert S: Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value. J Cancer Res Clin Oncol 134: 543-550, 2008. (Pubitemid 351422608)
11. Endo K, Kohnoe S, Watanabe A, Tashiro H, Sakata H, Morita M, Kakeji Y and Maehara Y: Clinical significance of Smac/DIABLO expression in colorectal cancer. Oncol Rep 21: 351-355, 2009.
12. Sekimura A, Konishi A, Mizuno K, Kobayashi Y, Sasaki H, Yano M, Fukai I and Fujii Y: Expression of Smac/DIABLO is a novel prognostic marker in lung cancer. Oncol Rep 11: 797-802, 2004.
13. Deveraux QL and Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 13: 239-252, 1999. (Pubitemid 29095796)
14. Sasaki H, Sheng Y, Kotsuji F and Tsang BK: Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60: 5659-5666, 2000.
15. Mizutani Y, Nakanishi H, Li YN, Matsubara H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara K, Takaha N, Ukimura O, Kawauchi A, Nonomura N, Bonavida B and Miki T: Overexpression of XIAP in renal cell carcinoma predicts a worse prognosis. Int J Oncol 30: 919-925, 2007.
16. Goyal L: Cell death inhibition: Keeping caspases in check. Cell 104: 805-808, 2001.
17. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fermandes-Alnemri T, Shi Y and Alnemri ES: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112-116, 2001. (Pubitemid 32225846)
18. Morizane Y, Honda R, Fukami K and Yasuda H: X-linked inhibitor of apoptosis function as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J Biochem 137: 125-132, 2005.
19. Hu S and Yang X: Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J Biol Chem 278: 10055-10060, 2003. (Pubitemid 36800260)
20. Fu J, Jin Y and Arend LJ: Smac 3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein. J Biol Chem 278: 52660-52672, 2003. (Pubitemid 38035863)